StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$32.88−0.44 (-1.32%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

SpyGlass Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for SpyGlass Pharma

SpyGlass Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More SpyGlass Pharma figures

See a number that looks wrong?